21 May 2019, Brisbane.
With a growing number of MedTech companies being established in the field of innovative and life-changing medical devices, Brisbane is quickly becoming a hub for medical engineers. WearOptimo was proud to celebrate the high calibre of Brisbane’s biomedical engineering community by hosting an Engineers Australia event at its headquarters on Tuesday 21st May.
Titled “Brisbane – A Biomedical Engineering Hub” – this highly successful networking event showcased two of Brisbane’s pioneering engineers who are changing medicine for the better through innovation. Speeches were given by Samuel Baker, Business Development Manager / Educator for Ottobock and Prof Mark Kendall, CEO and Founder of WearOptimo enterprise.
Samuel Baker spoke of his experiences in Ottobock, a global MedTech company in the field of prosthetics, orthotics and mobility and his career transition from academia to industry. The audience heard about the variety of unique settings in which Samuel has worked including hospitals, laboratories and even the Commonwealth and Invictus games.
Prof Mark Kendall summarised his 20-year experience in the field of medical device research and commercialisation, and spoke of the successful companies he has been involved with in his career. These have included PowderJect and PowderMed – companies founded to develop biolistics technology for vaccine delivery. With acquisitions by Chiron (PowderJect, 2003) and Pfizer (PowderMed, $400 million, 2006), these companies remain Oxford University’s most successful spinouts. On moving back to Brisbane as Professor of Biomedical Engineering at UQ, Mark invented the Nanopatch for vaccine delivery and founded the company Vaxxas in 2011 to drive forward its commercialisation.
In 2018, Mark joined the Australian National University and founded WearOptimo, where he now serves as CEO.